New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...

Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty (CPP), according to a study presented at ENDO 2025, the annual meeting of the ...

In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is associated with superior weight loss outcomes, according to a study presented at ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presen ...

New research shows that older adults who feel socially isolated may be more likely to develop diabetes and struggle with ...

Acquire, the Japanese game developer behind the iconic Tenchu series on PlayStation, has teamed up with Red Dune Games to ...

SAN FRANCISCO -- Age of menarche may provide several insights on long-term cardiometabolic and reproductive health, a ...

SAN FRANCISCO -- The investigational selective glucocorticoid receptor modulator relacorilant led to improvements in blood ...

ACQUIRE and Red Dunes Games entered into a multi-year co-partnership to produce original IPs, the first of its kind.